Vicarious Surgical Inc. Cash Flow Conversion Efficiency
Vicarious Surgical Inc. cash flow conversion efficiency. Based on the latest financial reports, Vicarious Surgical Inc. (RBOT) has a cash flow conversion efficiency ratio of -1.772x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-6.33 Million) by net assets ($3.57 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Vicarious Surgical Inc. (2019–2025)
Cash flow conversion efficiency of Vicarious Surgical Inc. from 2019 to 2025. This chart illustrates how Vicarious Surgical Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View RBOT stock price for real-time trading data and today's change.
Vicarious Surgical Inc. Cash Flow Conversion Ratio Explained
Vicarious Surgical Inc. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Vicarious Surgical Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Vicarious Surgical Inc. ranked by their cash flow conversion efficiency. Also see Vicarious Surgical Inc. market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Landore Resources Plc
LSE:LND
|
-1.772x |
|
Tower Resources plc
LSE:TRP
|
0.068x |
|
BENO Holding AG
XETRA:BENH
|
N/A |
|
abrdn Property Income Trust Ltd.
LSE:API
|
0.916x |
|
NEXTLEAF SOLUTIONS
F:L0MA
|
-0.085x |
|
Kasikornbank Public Company Limited
F:TFBF
|
0.050x |
|
GREENBANK CAPITAL
F:2TL
|
N/A |
|
Itim Group PLC
LSE:ITIM
|
0.123x |
Annual Cash Flow Conversion Efficiency for Vicarious Surgical Inc. (2019–2025)
The table below shows the annual cash flow conversion efficiency of Vicarious Surgical Inc. from 2019 to 2025. Review financial flexibility index of Vicarious Surgical Inc. to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $9.84 Million | $-45.08 Million | -4.580x | -328.17% |
| 2024-12-31 | $46.70 Million | $-49.96 Million | -1.070x | -68.21% |
| 2023-12-31 | $97.97 Million | $-62.30 Million | -0.636x | -15.37% |
| 2022-12-31 | $111.05 Million | $-61.21 Million | -0.551x | -37.55% |
| 2021-12-31 | $83.09 Million | $-33.30 Million | -0.401x | +43.90% |
| 2020-12-31 | $16.85 Million | $-12.04 Million | -0.714x | -28.18% |
| 2019-12-31 | $15.63 Million | $-8.71 Million | -0.557x | -- |
About Vicarious Surgical Inc.
Vicarious Surgical Inc. engages in the development and sale of single-port surgical robot in the United States. The company offers Vicarious Surgical System, a single-port surgical robot that virtually transports surgeons inside the patient to perform invasive surgery. Vicarious Surgical Inc. was founded in 2014 and is headquartered in Waltham, Massachusetts.